Operationalizing the scope of the Medicare drug negotiations
The Inflation Reduction Act of 2022 allowed Medicare to directly negotiate the prices of certain high-expenditure, single-source drugs without generic
Read MoreThe Inflation Reduction Act of 2022 allowed Medicare to directly negotiate the prices of certain high-expenditure, single-source drugs without generic
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Jan 23, 2025) The Inflation Reduction Act of 2022 (the Act),
Read More(By Sydney Lupkin for NPR) The Biden administration, in its last full weekday in office, is poised to announce the
Read More(Juliette Cubanski for The Kaiser Family Foundation Published: Nov 19, 2024) The Inflation Reduction Act of 2022 (the Act), signed
Read More(By Alexandra Murphy for Becker’s Hospital Review) As President-elect Donald Trump prepares to take office, the future of Medicare’s drug
Read More(By Craig Paloskey for The Kaiser Family Foundation published September 13, 2024) Allowing Medicare to negotiate drug prices on behalf
Read More(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More(Tammie Smith for The Kaiser Family Foundation published August 14, 2024) Among the 167 million people with employer-sponsored insurance in
Read More(By Chris Lee and Craig Palosky for The Kaiser Family Foundation published May 15, 2024) A new KFF poll finds
Read More(By Rachel Cohrs for STAT) WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug
Read More